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Available online 29 June 2016To determine the inﬂuence of cardiorespiratory ﬁtness (hereafter “ﬁtness”) and physical activity levels on
cardiometabolic risk factors in premenopausal women going through the menopause transition. An ancillary
study including 66 premenopausal women who participated to a 5-year observational, longitudinal study
(2004 to 2009 in Ottawa) on the effects of menopause transition on body composition and cardiometabolic
risk factors. Women underwent a graded exercise test on treadmill to measure peak oxygen uptake (VO2
peak) at year 1 and 5 and physical activity levels were measured using accelerometers. Cardiometabolic risk
factors included: waist circumference, fasting plasma lipids, glucose and insulin levels, HOMA-IR score,
c-reactive protein, apolipoprotein B (apoB) and resting systolic and diastolic blood pressure. Change in ﬁtness
was not associated with changes in cardiometabolic risk factors. The changes in total physical activity levels on
the other hand showed a signiﬁcant negative associationwith apoB levels. Three-way linearmixedmodel repeat-
ed measures, showed lower values of waist circumference, fasting triglycerides, insulin levels, HOMA-IR score,
apoB and diastolic blood pressure in women with a ﬁtness ≥30.0 mlO2 kg−1 min−1 compared to women with
a ﬁtness b30.0 mlO2 kg−1 min−1 (P b 0.05). However, only fasting triglycerides was lower in women with
physical activity levels ≥770.0 Kcal/day (P b 0.05). Between ﬁtness and physical activity levels, ﬁtness was
associated with more favorable values of cardiometabolic risk factors in women followed for 5 years during
the menopause transition.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Menopause1. Introduction
Cardiovascular disease (CVD) is the leading cause of mortality
among women in developed countries (Bittner, 2002). Many CVD risk
factors have been identiﬁed such as abdominal obesity, physical inactiv-
ity, diabetes, hypertension and dyslipidemia (Bittner, 2002; Pearson,
1999). Cardiorespiratory ﬁtness (hereafter “ﬁtness”) as well as physical
activity levels are important and independent predictors of CVD,
cardiac events and death among symptomatic and asymptomaticc Director, Institut de recherche
2e étage/Floor, Ottawa, ON K1K
. Prud'homme).
. This is an open access article underwomen (Blair & Jackson, 2001; Gulati et al., 2005; Berlin & Colditz,
1990; Hu et al., 2005).
Fitness is a physiological attribute, deﬁned by maximal oxygen
uptake (VO2 max) measured using a maximal exercise test (Lee et al.,
2011). A high ﬁtness level estimated in metabolic equivalents (METs)
has been deﬁned as the 2 highest quintiles, which represents ≥8.5
METs for women between the ages of 50–59 years according to the
Aerobics Center Longitudinal study (Sui et al., 2007). Furthermore, a
low ﬁtness value (b8.5 METs) was shown to be associated with a higher
incidence of CVDevents inmen andwomen (Sui et al., 2007). Conversely,
high ﬁtness has been found to be inversely associated with the levels of
visceral fat, insulin resistance, blood lipids and blood pressure as well as
with the prevalence of the metabolic syndrome (Abdulnour et al.,
2010; Arsenault et al., 2007; LaMonte et al., 2005; LaMonte & Blair,
2006) collectively reducing the risk of CVD.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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energy expenditure, including both leisure time and non-leisure time
activities (American College of Sports Medicine et al., 2006). The 2011
Canadian Physical Activity Guidelines for adults recommends at least
150 min of moderate-to-vigorous intensity of aerobic physical activity
per week (Tremblay et al., 2011 Feb). It has also been recommended
to expend a minimum of 150 kcal/day or 1000 kcal/week of moderate-
to-vigorous physical activity energy expenditure (Anon., 1996). Such
physical activity levels recommendations have been demonstrated to
be associated with increased health beneﬁts, by reducing the risk of
cardiometabolic risk factors and CVD in men and women (Hu et al.,
2005; Tremblay et al., 2011; Warburton et al., 2010; Dvorak et al.,
2000; Owens et al., 1990).
Despite the fact that several studies having simultaneously investi-
gated the association between ﬁtness and physical activity levels and
body composition, body fat distribution and cardiometabolic risk factors
(Lee et al., 2011; Dvorak et al., 2000; Eriksen et al., 2013; Minder et al.,
2014; Yu et al., 2013), controversy remains.While themajority reported
that ﬁtness ismore strongly associated than physical activity levelswith
CVD and cardiometabolic risk factors (Lee et al., 2011; Dvorak et al.,
2000; Minder et al., 2014; Yu et al., 2013), one study suggested that
physical activity level is as good as ﬁtness to predict individual health
(Eriksen et al., 2013). However, the majority of the studies used self-
reported questionnaire for the assessment of physical activity levels
(Lee et al., 2011; Eriksen et al., 2013; Minder et al., 2014; Yu et al.,
2013). Although, self-reported physical activity may be useful for
ranking physical activity levels in large epidemiological studies, it
lacks precision and validity (Dvorak et al., 2000) for longitudinal and
prospective studies compared to the measurement of total volume of
physical activity by accelerometry (Bassett et al., 2015). Furthermore,
accelerometer-derived physical activitymeasurements aremore closely
associated to cardiometabolic risk factors than that obtained from
self-reported questionnaire (Bassett et al., 2015).
The evidence supporting a relationship between ﬁtness and/or
physical activity levels and CVD risk factors has been well documented
in the general population. Still, it is questionable if these relationships
are the same in women going through the menopause transition. First,
this is a period in a woman's life that results in a progressive decrease
in estrogen (Lovejoy et al., 2008 Jun), which is associated with an in-
crease incidence and prevalence of cardiometabolic risk factors
(Lovejoy et al., 2008) and CVD (Rosano et al., 2007). Second, we have
previously reported, in the same cohort, that the time spent performing
light physical activity have a greater effect on adiposity during
menopause transition than moderate and/or vigorous physical activity
(Riou et al., 2014). Third, the intensity of non-leisure time activities is
lower than the relative intensity necessary to improve ﬁtness
(American College of Sports Medicine et al., 2006).
Thus, the aim of the present studywas to determine the inﬂuence of
ﬁtness and physical activity levels on cardiometabolic risk factors in
non-obese women going through the menopause transition. We tested
the following hypothesis: ﬁtness and physical activity levels would be
relatedwith a favorable cardiometabolic risk factors inwomen followed
through the menopause transition.
2. Methods
2.1. Subjects
The study includes data from healthy premenopausal women aged
between 47 and 55 years who participated in a 5-year longitudinal
study from 2004 to 2009 (MONET Study: Montreal Ottawa New
Emerging Team) (Abdulnour et al., 2012). For the purpose of this
secondary analysis, 66 out of the 91 participants who completed
the original study were included, based on peak oxygen uptake (VO2
peak) and physical activity levels value availability at years 1 and 5. How-
ever, no differences were observed for baseline characteristics (data notshown) between those who completed the study and the sub-sample of
participant used in the present analysis. Premenopausal women were
included if they met the following criteria: (1) premenopausal status
(two menstruations in the last three months, no increase in cycle
irregularity in the 12 months preceding testing, and a plasma follicular-
stimulating hormone level b 30 IU/l as a mean of veriﬁcation); (2) aged
between 47 and 55 years; (3) no surgically-induced menopause;
(4) non-smoker; (5) BMI between 20 and 29 kg/m2; and (6) reported
weight stability (±2 kg) for ≥6 months before enrolment in the study.
Exclusion criteria were: (1) pregnant women or planned to become
pregnant; (2) had medical problems that could have interfered with
outcome variables including cardiovascular and/or metabolic diseases;
(3) were taking oral contraceptives or hormone replacement therapy;
(4) had high risk for hysterectomy; and (5) had a history of drug
and/or alcohol abuse. Prior to inclusion in the study, written
informed consent was obtained from each participant. This study
was conducted according to the guidelines of the Declaration of
Helsinki, and received the approval from the University of Ottawa
and the Montfort Hospital Ethics committees.
2.2. Menopausal status
Menopausal status was determined yearly by self-reported ques-
tionnaire about menstrual bleeding and its regularity and follicle-
stimulating hormone (FSH) levels were measured annually during the
early follicular phase to verify the menopausal status. Women were
classiﬁed as premenopausal if they reported no change in menstrual
cycle frequency and perimenopausal if they reported changes in
menstrual frequency and/or amenorrhea for 3–11 months. Finally
women were classiﬁed as postmenopausal based on their ﬁnal
menstrual period (FMP) and conﬁrmed by 12 month of amenorrhea
(Soules et al., 2001).
2.3. Anthropometric assessment
Body weight and height were measured with a BWB-800AS
digital scale and a Tanita HR-100 height rod, respectively (Tanita
Corporation of America, Inc. Arlington Heights, IL). Body mass
index (BMI) was then calculated [body weight kg/height (m2)].
Waist circumference (mean of two measures) was determined
using a Gulick tape at the mid-distance between the lowest rib and
the iliac crest (Canadian Society for Exercise Physiology, 2003).
Body composition (fat mass and lean body mass) and % body fat
were measured using dual-energy X-ray absorptiometry (DEXA)
(GE-LUNAR Prodigy module, GE Medical Systems, Madison, Wi,
USA) as previously described (Abdulnour et al., 2012).
2.4. Cardiorespiratory ﬁtness
A graded progressive exercise test on the treadmill was performed
to measure VO2 peak by indirect calorimetry. The progressive test
consisted of 3-minute stages starting with a speed of 3.4 mph and a
slope of 0% with an increasing workload to the point of participant
exhaustion (speed increased to 4.0 mph by stage 6, 5.2 mph by stage
8 and 6.0 mph by stage 10; slope increased by 4% at every stage).
Heart rate, blood pressure and the rate of perceived exertion (Borg
scale) (Borg, 1982) were taken at rest and at the end of each stage dur-
ing the test. Breath-by-breath samples of expired air were collected
through a mouthpiece during the test, and measurements of VO2
and VCO2 were obtained using a Vmax 229 series metabolic cart
(SensorMedics Corporation, Yorba Linda, CA). The indirect calorimetry
unit was calibrated before each test according to the manufacturer's
speciﬁcations.
After a brief warm up on the treadmill, women performed the exer-
cise test. The test was terminated when at least 2 of the following
criteria were achieved (Gulati et al., 2005): 1) predicted maximal
Table 1
Anthropometric and cardiometabolic characteristics of premenopausal women (n = 66)
at baseline (MONET study 2004–2009, Ottawa).
Variables Mean ± SD Minimum Maximum
Age (yrs) 49.8 ± 1.9 47 54
Body mass index (kg/m2) 23.2 ± 2.4 19.3 28.7
% Body fat 31.1 ± 7.0 18.2 41.7
Fat mass (kg) 19.0 ± 5.6 9.6 29.9
Lean body mass (kg) 38.9 ± 3.9 31.1 47.3
Waist circumference (cm) 78.1 ± 7.1 62.2 93.7
Triglycerides (mmol/l) 0.84 ± 0.31 0.41 1.98
Total cholesterol (mmol/l) 4.39 ± 0.69 3.05 6.23
HDL-C (mmol/l) 1.53 ± 0.33 0.81 2.29
LDL-C (mmol/l) 2.47 ± 0.65 1.33 4.25
TC/HDL-C 3.01 ± 0.79 1.78 5.40
Fasting Glucose (mmol/l) 4.79 ± 0.38 3.80 5.70
Fasting Insulin (uU/ml) 11.45 ± 4.02 5.03 32.07
HOMA-IR 2.45 ± 0.90 1.14 6.98
CRP (mg/l) 1.70 ± 1.90 0.20 10.40
apoB (g/l) 0.74 0.47 1.20
VO2 peak (mlO2 kg−1 min−1) 33.6 ± 6.5 20.9 52.0
Physical activity (kcal/day) 829.9 ± 266.4 326.3 1904.7
n: number of subjects (number differ because of missing data); SD: standard deviation;
HDL-C: high-density lipoproteins cholesterol; LDL-C: low-density lipoproteins cholester-
ol; TC: total cholesterol; HOMA-IR: homeostasis model assessment; CRP: C-reactive
protein; apoB: apolipoprotein B.
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or decreased with an increase in workload, or 4) rate of Borg-type scale
reached ≥19. VO2 peak was considered as the highest 30 s average VO2
reached during the test.
2.5. Physical activity levels
An accelerometer (Actical; Mini Mitter Co, Inc., Bend, OR) was used
tomeasure physical activity levels in kcal/day and time spent in physical
activity of various intensities (sedentary, light, moderate and vigorous)
per week. Once a year, participants wore the accelerometer upon
waking up and took it off just before going to bed for 7 consecutive
days, as previously described (Abdulnour et al., 2012). 24 h of
continuous recording was performed by the accelerometers and time
spent performing sedentary exercise was also considered when partici-
pants were not wearing the device (sleep time). Daily activity levels
measured via accelerometywere found to be a good predictor of energy
expenditure (r = 0.92–0.97) (Bouten et al., 1997). The accelerometers
used to measure physical activity energy expenditure in this study
were also validatedwith the use of doubly labeledwatermeasurements
(Goris et al., 2001).
2.6. Resting blood pressure
Qualiﬁed research assistants measured supine resting blood
pressure manually from the left arm after participants had been resting
quietly for 5min using a standard stethoscope and amercury sphygmo-
manometer. For this measurement, an appropriate cuff size was select-
ed for each participant based on arm circumference. Assessment of
resting blood pressure was standardized according to the (American
College of Sports Medicine et al., 2000) SBP was considered as the ﬁrst
detectable Korotkoff sound (phase 1) and DBP was considered as the
last detectable Korotkoff sound (phase 5) (Chobanian et al., 2003).
2.7. Blood sampling
Blood samples were taken after a 12-h overnight fast. Plasma insulin
concentrations were measured in duplicate by radioimmunoassay
using 125I-labeled human insulin and a human insulin antiserum
(Millipore, St. Charles, MO, USA). Plasma glucose levels were deter-
mined using spectrophotometric analysis after conversion of glucose
to glucose-6-phosphate by hexokinase (Sigma-Aldrich Canada Ltd.,
Oakville, ON, CAN; Fisher Scientiﬁc Limited, Nepean, ON, CAN). Insulin
resistance was estimated using the homeostasis model assessment
[HOMA-IR = (fasting glucose × fasting insulin)/22.5]. Total cholesterol
(TC), high-density-lipoproteins cholesterol (HDL-C), and triglycerides
(TG) were analyzed using the Vitros 950 immunoassay analyzer
(Ortho Clinical Diagnostics, Johnson & Johnson Company, Markham,
ON, CAN) at a wavelength of 540 nm. TC, HDL-C, and TG were used
in the Friedewald (Friedewald et al., 1972) formula to calculate
low-density-lipoproteins cholesterol (LDL-C) concentration. Serum
c-reactive protein (CRP), was assessed by immunonephelometry
on an Image analyzer (Beckman-Coulter, Villepinte, France) with
detection limits of 0.20 mg/l. Apolipoprotein B (apoB) was assessed
by immunoturbidimetry (Architect, Abbott, Rungis, France) with
detection limits of 0.03 g/l. All measures of blood proﬁle presented
a coefﬁcient of variation of b15%.
2.8. Statistical analysis
Data are presented as means ± standard deviation. Variables were
ﬁrst checked for normality. Consequently, only TG and CRP were log-
transformed to normalize the distribution. ANOVA was performed to
compare ﬁtness and physical activity levels between menopause status
(premenopause, perimenopause and postmenopause), for the purpose
of this analysis the database was transformed into cases as previouslydescribed (Abdulnour et al., 2012). Pearsons' correlationswereperformed
to document the associations between the changes (year 5 - baseline) in
ﬁtness, physical activity levels and the changes observed in variables of
interest. Participants were divided into groups based on their VO2
peak (b30.0 vs. ≥30.0 mlO2 kg−1 min−1) according to the high ﬁtness
(8.5 METs) classiﬁcation for age and sex-speciﬁc estimated metabolic
equivalent levels of ﬁtness (Sui et al., 2007). Furthermore, we elected to
use daily total volume of physical activity levels expressed in kcal/day.
The latter has shown to be a better metric than time spent in various
physical activity intensities because it incorporates the full continuum
of physical activity intensities (Bassett et al., 2015). Participants
were therefore divided in two sub-group based on physical activity
levels (b770.0 vs. ≥770.0 kcal/day). Three-way linear mixed model
repeated measures analyses were used for determination of main
effects on cardiometabolic risk factors (waist circumference, fasting
plasma lipids, glucose and insulin levels, HOMA-IR score, CRP, apoB
and resting systolic and diastolic blood pressure). Time (baseline
and year 5) was considered as a within-subject factor; VO2 peak
(low b 30.0 vs. high ≥ 30.0 mlO2 kg−1 min−1) and physical activity
levels (b770.0 vs. ≥770.0 kcal/day) were considered as between-subject
factor. Results are expressed as the mean ± standard deviation. A P
value ≤0.05 was considered as signiﬁcant. SPSS 17.0 for windows
(SPSS Inc. Chicago, IL, USA) was used to perform statistical analyses.3. Results
Participants' characteristics are presented in Table 1. At baseline,
mean age of the participants was 49.8 ± 1.9 years (range: 47 to
54 years), and % body fat was 31.1 ± 7.0 (range: 18.2 to 41.7%). The
mean VO2 peak was 33.6 ± 6.5 (range: 20.9 to 52.0 mlO2 kg−1 min−1)
and daily physical activity levels was 829.9 ± 266.4 (range: 326.3 to
1904.7 kcal/day). All 66 women were premenopausal at year 1. By
the end of year 5, 4 were still premenopausal (FSH: 26.5 ± 24.7 IU/l),
17 were perimenopausal (FSH: 48.6 ± 38.9 IU/l) and 46 had become
postmenopausal (FSH: 85.2 ± 29.5 IU/l).
To analyze the effect ofmenopause transition onﬁtness and physical
activity levels, the database was transformed into cases based on
menopausal status (Abdulnour et al., 2012). As a result, no signiﬁcant
differences were observed between menopause group (premenopause
vs. perimenopause vs. postmenopause) for VO2 peak, and for physical
activity levels (Table 2).
Table 2
Comparison of ﬁtness and physical activity levels between menopausal status (MONET
study 2004–2009, Ottawa).
Menopause status P
Value
Premenopause Perimenopause Postmenopause
n 66 17 45
Fitness
(mlO2 kg−1 min−1)
33.9 ± 6.3 33.9 ± 6.1 32.7 ± 6.6 =0.56
n 66 15 41
Physical activity levels
(kcal/day)
825.6 ± 266.7 849.0 ± 244.2 803.9 ± 256.6 =0.81
n: number of subjects. Results are expressed as mean ± standard deviation.
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ﬁtness, physical activity levels and the changes observed in cardiomet-
abolic risk factors were preformed. As a result, only the change in
physical activity levels showed signiﬁcant negative association with
apoB (P b 0.05). No signiﬁcant correlations were observed between
changes in ﬁtness and cardiometabolic risk factors (Table 3).
Three-way linear mixed model repeated measures (Table 4) were
performed to document the main effect of time (baseline and year 5),
ﬁtness, and physical activity levels on cardiometabolic risk factors, in
women going through the menopause transition. A signiﬁcant effect
of timewas observed for various indices of cardiometabolic risk factors,
indicating an overall increase over time, with the exception of fasting
plasma glucose and CRP, which showed a decrease in time. Signiﬁcant
effect of ﬁtness was also observed for waist circumference, fasting
TG, insulin, HOMA-IR score, apoB and diastolic blood pressure.
These variables were signiﬁcantly lower in women with a VO2
peak ≥30.0 mlO2 kg−1 min−1 compared to women with a VO2 peak
b30.0 mlO2 kg−1 min−1. Despite signiﬁcant effect of physical activi-
ty level was observed for waist circumference and TG (b0.05) only
the TG was lower in women with physical activity levels
≥770.0 Kcal/day. Finally, no ﬁtness × physical activity levels interac-
tion was observed for any variables of interest.
4. Discussion
The present study determined the inﬂuence of objectivemeasures of
ﬁtness and physical activity levels on cardiometabolic risk factors inTable 3
Relationships between 5-year changes of ﬁtness, physical activity levels and changes
in cardiometabolic risk proﬁle in women transitioning from pre to post-menopausal
(MONET study 2004–2009, Ottawa).
Fitness Physical activity levels
n 65 56
Waist circumference −0.16 −0.06
n 61 55
Triglycerides −0.14 −0.03
Total cholesterol −0.13 −0.06
HDL-C 0.09 0.16
LDL-C −0.18 −0.26
TC/HDL-C ratio −0.19 −0.26
Fasting glucose −0.06 −0.01
Fasting insulin −0.18 −0.07
HOMA-IR −0.19 −0.06
CRP −0.02 −0.24
apoB 0.01 −0.38⁎⁎
n 59 53
Blood pressure
Systolic −0.05 0.25
Diastolic −0.004 0.19
n: Number of subjects; HDL-C: high-density lipoproteins cholesterol; LDL-C: low-density
lipoproteins cholesterol; TC: total cholesterol; HOMA-IR: homeostasis model assessment;
CRP: c-reactive protein; apoB: apolipoprotein B. Triglycerides and CRPwere log-converted
for analysis.
⁎⁎ P b 0.01.non-obese premenopausal women going through menopause transi-
tion. According to the mixed model repeated measures, we found that
ﬁtness had independent effects on measures of waist circumference,
fasting TG, insulin, HOMA-IR score, apoB and diastolic blood pressure.
The results showed overall lower values in women with a high ﬁtness.
Physical activity levels, on the other hand, was negatively associated
with apoB, however this observation no longer remained in the
repeated measures analysis. In fact, physical activity did not have an
independent impact on more favorable values of cardiometabolic
risk factors compared to ﬁtness. This suggests that ﬁtness may have
greater cardioprotective effects than physical activity levels in women
transitioning to menopause. These ﬁndings further support existing
studies (Lee et al., 2011; Dvorak et al., 2000; Minder et al., 2014; Yu
et al., 2013) that reported ﬁtness as a stronger correlate of cardiometa-
bolic risk factors, despite the use of accelerometers in this study for the
measurement of physical activity levels compared to self-reported
questionnaire. One study reported, in a sample of Chinese women
aged 55 to 69, that both physical activity (self-reported questionnaire)
and ﬁtness were associated with the prevalence of the metabolic syn-
drome, adjusted for confounding variables (Yu et al., 2013). However,
when physical activity was further adjusted for ﬁtness, the association
with metabolic syndrome was eliminated; when ﬁtness was adjusted
for physical activity, the association remained (Yu et al., 2013). Another
study reported, in 53men (68± 9 years) and 63women (67±7 years)
that high ﬁtness, independent of physical activity (measured by doubly
labeled water and accelerometer), showed lower levels of fasting tri-
glycerides, total cholesterol, TC/HDL-C, insulin and waist circumference
(0.01 N P b 0.05) (Dvorak et al., 2000).
Overall, the results are in line with the classical knowledge that ﬁt
individuals have better CVD risk factors proﬁle than unﬁt subjects
(Haddock et al., 1998; Lee et al., 2005; VainionpaÌˆaÌˆ et al., 2007;
Wong et al., 2004). However, even if higher values of cardiometabolic
risk factors were observed in our women with lower ﬁtness, the
absolute values were still within normal ranges. This can be explained
by the fact that this cohort is composed of healthy non-obese women
with no major cardiometabolic complications. Also the participants'
mean waist circumference value is lower than the reported thresholds
of 88.0 cm; which has been associated with an increased risk of
cardiometabolic disturbance in women (Klein et al., 2007).
Even though physical activity levels was not a better correlate of
cardiometabolic risk factors, it is known to be an important determinant
of ﬁtness (LaMonte & Blair, 2006). However, in the present study, we
did not ﬁnd a signiﬁcant correlation between physical activity levels
and ﬁtness (data not shown). This supports the idea that these two
phenotypes may act in an independent manner on various CVD risk
factors (Dvorak et al., 2000) and could explain why we did not observe
a ﬁtness x physical activity levels interactions in the present study.
Finally, in healthy women, menopause per se was found to be
associated with decrease in ﬁtness through cardiopulmonary alter-
ations affected by estrogen deﬁciency and a reduced level of nitric
oxide (Mercuro et al., 2006). These alterations account partially for the
impairment of endothelium-dependent vasodilation, preventing O2
ﬂow to match the increase O2 requirement during exercise (Mercuro
et al., 2006). Despite what has been reported in the previous study, no
effect of the menopausal status was observed for ﬁtness in the present
sub-group aswell as reported by our group for thewholeMONET cohort
(Abdulnour et al., 2012). This is partly due to the fact that the participant
remained fairly active, based on the absence of a signiﬁcant change in
physical activity levels between menopausal status, in this study, and
during the 5 years follow-up, as reported elsewhere (Duval et al., 2013).
Our study presents some limitations. First, the population studied
consisted of healthy women with a BMI b 30 kg/m2. Therefore, our
ﬁndings cannot be generalized to the whole population with a wide
range of BMIs. Nonetheless, it is important to mention that 45% of the
women aged between 40 and 59 years in the Canadian population
present a normal BMI and 76% have a BMI b 30 kg/m2. Second, we
Table 4
Cardiometabolic risk factors characteristics of women by time point, ﬁtness (mlO2 kg−1 min−1) and physical activity levels (kcal/day) (MONET study 2004–2009, Ottawa).
Fitness b 30.0
Mean ± SD
Fitness ≥ 30.0
Mean ± SD
Physical activity
levels b 770.0 Mean ± SD
Physical activity
levels ≥ 770.0 Mean ± SD
Independent effects
(P value)
Baseline Year 5 Baseline Year 5 Baseline Year 5 Baseline Year 5 Time Fitness PAEE
n 24 28 42 37 32 23 34 33
Waist circumference (cm) 81.7 ± 6.6 82.5 ± 7.4 76.1 ± 6.5 74.3 ± 4.8 75.6 ± 6.9 76.4 ± 6.7 80.5 ± 6.5 79.1 ± 7.7 NS b0.001 b0.05
n 24 27 42 34 32 24 34 30
Triglycerides (mmol/l) 0.96 ± 0.38a 0.94 ± 0.38b 0.76 ± 0.24 0.85 ± 0.36 0.89 ± 0.39 1.01 ± 0.41 0.78 ± 0.20c 0.77 ± 0.28d NS b0.05 b0.05
Total cholesterol (mmol/l) 4.52 ± 0.69 5.02 ± 0.79 4.31 ± 0.69 4.87 ± 0.72 4.24 ± 0.60 4.90 ± 0.77 4.53 ± 0.76 5.98 ± 0.74 b0.001 NS NS
HDL-C (mmol/l) 1.52 ± 0.40 1.68 ± 0.33 1.53 ± 0.29 1.73 ± 0.36 1.47 ± 0.32 1.68 ± 0.37 1.58 ± 0.34 1.74 ± 0.33 b0.001 NS NS
LDL-C (mmol/l) 2.53 ± 0.73 2.87 ± 0.69 2.44 ± 0.61 2.75 ± 0.60 2.37 ± 0.53 2.75 ± 0.62 2.57 ± 0.74 2.85 ± 0.67 b0.001 NS NS
TC/HDL-C 3.19 ± 1.02 3.11 ± 0.84 2.90 ± 0.60 2.90 ± 0.60 3.01 ± 0.72 3.01 ± 0.68 3.00 ± 0.85 2.97 ± 0.77 NS NS NS
Fasting glucose (mmol/l) 4.86 ± 0.49 4.63 ± 0.44 4.75 ± 0.31 4.55 ± 0.36 4.76 ± 0.35 4.57 ± 0.35 4.82 ± 0.42 4.60 ± 0.44 b0.001 NS NS
Fasting insulin (uU/ml) 13.2 ± 5.0 11.8 ± 2.9 10.5 ± 2.9 10.2 ± 2.8e 11.6 ± 5.1 10.7 ± 2.7 11.2 ± 2.7 11.0 ± 3.1f NS b0.01 NS
HOMA-IR 2.86 ± 1.11 2.46 ± 0.66 2.21 ± 0.66 2.12 ± 0.55g 2.48 ± 1.12 2.20 ± 0.47 2.42 ± 0.64 2.34 ± 0.75d NS b0.01 NS
CRP (mg/l) 2.02 ± 2.01 1.47 ± 1.52h 1.51 ± 1.83i 0.99 ± 1.63j 1.71 ± 1.97 1.35 ± 1.98 1.69 ± 1.86k 1.05 ± 1.08k b0.01 NS NS
apoB (g/l) 0.78 ± 0.18 0.80 ± 0.19h 0.72 ± 0.12i 0.71 ± 0.18j 0.74 ± 0.13 0.73 ± 0.17 0.75 ± 0.16k 0.76 ± 0.21k NS b0.05 NS
n 24 27 42 33 32 22 34 32
Resting blood pressure
Systolic (mmHg) 114.4 ± 9.6 119.9 ± 12.3 116.2 ± 11.6 119.1 ± 11.5 115.3 ± 11.6 121.5 ± 12.1 115.8 ± 10.3 117.5 ± 11.3 NS NS NS
Diastolic (mmHg) 75.4 ± 6.2 75.3 ± 7.4 71.6 ± 7.6 73.3 ± 7.4 71.9 ± 7.8 75.6 ± 8.5 73.9 ± 6.8 73.9 ± 6.3 NS b0.05 NS
PAEE: physical activity energy expenditure; N: number of subjects; HDL-C: high-density lipoproteins cholesterol; LDL-C: low-density lipoproteins cholesterol; TC: total cholesterol;
HOMA-IR: homeostasis model assessment.
Linearmixedmodels repeatedmeasures; Independent effect of time (within subject factor); Independent effect of ﬁtness (between subject factor); Independent effect of PAEE (between
subject factor).
Triglyceride and CRP were log-converted for statistical analysis and reconverted for presentation in table format.
a n = 23.
b n = 26.
c n = 33.
d n = 29.
e n = 35.
f n = 31.
g n = 33.
h n = 28.
i n = 40.
j n = 36.
k n = 32.
281J. Abdulnour et al. / Preventive Medicine Reports 4 (2016) 277–282used data taken fromyear 1 and year 5, based on ﬁtness and physical ac-
tivity levels availability. Therefore we could not account for ﬁtness and
physical activity levels at every year and between the yearly testing
sessions during the 5-year follow-up. Finally, because we worked with
healthy premenopausal women at low risk for CVD, the duration of
the follow-up might be insufﬁcient to capture the magnitude of the ef-
fect of menopause transition on cardiometabolic risk factors. Despite
these limitations, the well-characterized cohort of healthy non-obese
(BMI b 30 kg/m2) physically active women followed for 5 years
strengthens the present study. We used indirect calorimetry and
accelerometry, for the measurement of VO2 peak and physical activity
levels respectively, which are valid and highly reproducible measure
of these phenotype (Bassett et al., 2015; Goris et al., 2001; Vanhees
et al., 2005).5. Conclusion
The results of this study suggest that menopause does not have an
impact on ﬁtness and physical activity levels expressed in kcal/day.
Furthermore, ﬁtness was associated with more favorable values
of cardiometabolic risk factors compared to physical activity
levels in active non-obese premenopausal women transitioning
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